I.V.F. patients are faced with a growing list of costly “add-ons.” For one such test, some say more robust research is needed to support its effectiveness. By Amy Klein For patients undergoing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback